HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I-M Shih Selected Research

3-methyladenosine

2/2012NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I-M Shih Research Topics

Disease

3Neoplasms (Cancer)
02/2012 - 05/2008
2Ovarian Neoplasms (Ovarian Cancer)
02/2012 - 05/2009
2Carcinoma (Carcinomatosis)
05/2009 - 05/2008

Drug/Important Bio-Agent (IBA)

2Cisplatin (Platino)FDA LinkGeneric
02/2012 - 05/2008
2Paclitaxel (Taxol)FDA LinkGeneric
05/2009 - 05/2008
13-methyladenosineIBA
02/2012
1Beclin-1IBA
02/2012
1Chloroquine (Aralen)FDA LinkGeneric
02/2012
1Pharmaceutical PreparationsIBA
02/2012
1Small Interfering RNA (siRNA)IBA
02/2012
1Biological ProductsIBA
05/2009
1Carboplatin (JM8)FDA LinkGeneric
05/2008
1Docetaxel (Taxotere)FDA Link
05/2008
1DNA (Deoxyribonucleic Acid)IBA
05/2008

Therapy/Procedure

1Drug Therapy (Chemotherapy)
02/2012